Stock 88

[anonymous]

Stock is soaring on future growth.

 

[anonymous]

Gilead Oncology, the new frontier.

 

[anonymous]

Thanks god for all those blacks we promoted. Really paying off with stock price. See all those diversity doubters seeing the benefits now?? Huh.

 

[anonymous]

They key is our data and growth of extended prevention as techbology could be industry breaking for future products.
The risk of growth is Oncology as Trov is taking up too much money & expenses thus worse NET Profit on any of Gilead drugs. Need the Onc pipeline to come through.
Now that covid is the common flu, Remdesivir $4-5 Billion a will be able to pay for a lot of overhead & expenses in Onc to achieve those long term compounds.

 

[anonymous]

Target for break out is 91, if was 88 and settled. Technically if the stock breaks 91 then next resistance is 115. I d cash in some profits at 100 and leave some to ride.
2023 looks very likely G can get into 3 digits price.

 

[anonymous]

Thanks god for all those blacks we promoted. Really paying off with stock price. See all those diversity doubters seeing the benefits now?? Huh.

Your obsession with “all those blacks” is palpable. Cry harder, incel.

 

[anonymous]

The only people to thank here is Johanna and Dan for mainlining Onc assets. All the clowns shut up quick pointing fingers but love it or leave it, they are the only ones making big boy decisions. The rest are yes men and women.